is semaglutide for diabetes (Ozempic/Wegovy) shows 3-year efficacy blood sugar control and weight loss Peptide of the Week: Semaglutide

Individuals who have difficulty maintaining a healthy weight recommended for their gender, size, and body characteristics may now have another reliable and safe prescription treatment option

It is very important and relevant that those who took the highest dose of the drug - retatrutide - and stayed with the drug - lost about 29% of their weight

Projected commercial pricing When Eli Lilly eventually brings retatrutide to market, likely in late 2027 or 2028, analysts project a list price of $1,000 to $1,500 per month based on comparable GLP-1 medications like Mounjaro and Ozempic

Current Opinion in Molecular Therapeutics

Boran AD, Iyengar R

However, individual peptide-based medications and therapies have received FDA approval